Reddy's Laboratories (NYSE: RDY) announced today that it has launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Zometa([R]) (zoledronic acid) 4 mg/5 mL Injection in the US market on March 4, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr.
What does ZA stand for?
ZA stands for Zoledronic Acid (drug)
This definition appears very rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of ZA
We have 2 other meanings of ZA in our Acronym Attic
- Zarephath (NJ, USA)
- Zeger-Abrams (est. 1977; Glenside, PA)
- Zeitausgleich (German: compensatory time off)
- Zelda's Adventure (gaming)
- Zenith Angle
- Zero Adjusted
- Zero Adjuster
- Zero Administration (networking)
- Zero and Add
Samples in periodicals archive:
5] Until recently, intravenous (IV) zoledronic acid was the only treatment approved in Canada for reducing the risk of SREs in CRPC patients with bone metastases.
15, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today presented data comparing the effects of FORTEO and zoledronic acid on transiliac crest bone biopsies at six months in postmenopausal women with osteoporosis, based on additional analysis of data from the SHOTZ trial.
FROM THE ANNUAL MEETING OF THE AMERICAN SOCIETY FOR BONE AND MINERAL RESEARCH SAN DIEGO-Once-yearly intravenous zoledronic acid in men with osteoporosis reduced their risk of vertebral fractures by 67% over 2 years, compared with placebo, in a large, multinational, phase III randomized clinical trial.
Intravenous zoledronic acid should not be offered routinely to women with early breast cancer, say researchers, after a large trial found it had no discernible effect on recurrence or survival over five years.
Michela Quirino and colleagues from the Catholic University of the Sacred Heart in Rome have reported important new evidence that zoledronic acid may be able to prevent lung cancer metastases from recruiting the new blood vessels they need to survive.
The five-year study, known as the AZURE, also known as zoledronic acid said the drug was found to have no impact on "disease-free survival, professor of medical oncology at the University of Sheffield.
Intravenous bisphosphonate therapy Intravenous bisphosphonate studies encompassing 2600 pre- and postmenopausal women with early breast cancer and utilising zoledronic acid provide the main support for the use of bisphosphonates in AI-induced bone loss.